Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

608 ARTÍCULOS , VIENDO DEL 451 AL 465

Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders

Jellinger KA.

J Neural Transm (Vienna). 2019 Aug;126(8):933-995. doi: 10.1007/s00702-019-02028-6. Epub 2019 Jun 18.

Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders

Jellinger KA.

J Neural Transm (Vienna). 2019 Aug;126(8):997-1027. doi: 10.1007/s00702-019-02030-y. Epub 2019 Jun 24.

Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders

Peralta C, Biafore F, Depetris TS, Bastianello M.

Curr Neurol Neurosci Rep. 2019 Jun 29;19(8):56. doi: 10.1007/s11910-019-0966-3.

Antisense therapies for movement disorders

Scoles DR, Pulst SM.

Mov Disord. 2019 Aug;34(8):1112-1119. doi: 10.1002/mds.27782. Epub 2019 Jul 8.

The interindividual variability of transcranial magnetic stimulation effects: Implications for diagnostic use in movement disorders

Latorre A, Rocchi L, Berardelli A, Bhatia KP, Rothwell JC.

Mov Disord. 2019 Jul;34(7):936-949. doi: 10.1002/mds.27736. Epub 2019 Jun 10.

Diagnosis of Huntington's disease via sequential 18F-DOPA and 18F-FDG PET/MRI

Michler E, Hoberück S, Martino F, Platzek I, Kotzerke J.

Nuklearmedizin. 2019 Sep;58(5):403-404. doi: 10.1055/a-0972-0698. Epub 2019 Jul 25.

Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders

Antonazzo M, Botta M, Bengoetxea H, Ruiz-Ortega JÁ, Morera-Herreras T.

Int Rev Neurobiol. 2019;146:229-257. doi: 10.1016/bs.irn.2019.06.012. Epub 2019 Jun 28.

Chorea

Termsarasab P.

Continuum (Minneap Minn). 2019 Aug;25(4):1001-1035. doi: 10.1212/CON.0000000000000763.

Movement Disorders in Children

Pearson TS, Pons R.

Continuum (Minneap Minn). 2019 Aug;25(4):1099-1120. doi: 10.1212/CON.0000000000000756.

Huntington's disease: a forensic risk factor in women

Chu EM, O'Neill M, Purkayastha DD, Knight C.

J Clin Mov Disord. 2019 Jul 24;6:3. doi: 10.1186/s40734-019-0078-x. eCollection 2019.

Worsening of movement disorder following treatment with electroconvulsive therapy in a patient with Huntington's disease

Abeysundera H, Campbell A, Sarma S.

BMJ Case Rep. 2019 Aug 10;12(8):e230389. doi: 10.1136/bcr-2019-230389.

Uncommon Movement Disorders in Chronic Hepatic Disease with Response to Rifaximin

Sousa AL, Salgado P, Alves JE, Silva S, Ferreira S, Magalhães M.

Tremor Other Hyperkinet Mov (N Y). 2019 Aug 2;9. doi: 10.7916/tohm.v0.649. eCollection 2019.

Eye movement abnormalities in movement disorders

Lal V, Truong D.

Clin Park Relat Disord. 2019 Aug 30;1:54-63. doi: 10.1016/j.prdoa.2019.08.004. eCollection 2019.

Neurodegeneration with Brain Iron Accumulation: Two Additional Cases with Dystonic Opisthotonus

Mehta S, Lal V.

Tremor Other Hyperkinet Mov (N Y). 2019 Aug 21;9. doi: 10.7916/tohm.v0.683. eCollection 2019.

Recognizing Movement Disorder Emergencies - A Practical Review For Non-Neurologist

Hakeem H, Nasir M, Khan MF, Syed NM, Rajput HM, Ahmed A, Javed MA, Bhatti DE.

J Ayub Med Coll Abbottabad. 2019 Jul-Sep;31(3):448-453.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias